hsa-miR-3529-5p through F2RL3 Regulation as an Enhancer of Sensitivity to Cisplatin
- DOI
- 10.1007/s12291-024-01268-y
- Published
- 2024-09-25
- Container
- Indian Journal of Clinical Biochemistry
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s12291-024-01268-y,
title = {hsa-miR-3529-5p through F2RL3 Regulation as an Enhancer of Sensitivity to Cisplatin},
author = {Nasibeh Sargazi Moghaddam and Baharak MohammadFakhim and Mohammad Sharifi and Atefeh Rajabian and Maryam Hariri and Mahmoud Khansari and Mohammad Saeed Soleimani Meigoli and Reza Morovatshoar and Sahar Hosseini and Niloufar Jafari Namini and Kamran Ghaedi and Nasrin Fattahi Doaltabadi},
year = {2024},
journal = {Indian Journal of Clinical Biochemistry},
doi = {10.1007/s12291-024-01268-y},
url = {https://doi.org/10.1007/s12291-024-01268-y}
}RIS
TY - JOUR TI - hsa-miR-3529-5p through F2RL3 Regulation as an Enhancer of Sensitivity to Cisplatin AU - Nasibeh Sargazi Moghaddam AU - Baharak MohammadFakhim AU - Mohammad Sharifi AU - Atefeh Rajabian AU - Maryam Hariri AU - Mahmoud Khansari AU - Mohammad Saeed Soleimani Meigoli AU - Reza Morovatshoar AU - Sahar Hosseini AU - Niloufar Jafari Namini AU - Kamran Ghaedi AU - Nasrin Fattahi Doaltabadi PY - 2024 JO - Indian Journal of Clinical Biochemistry DO - 10.1007/s12291-024-01268-y UR - https://doi.org/10.1007/s12291-024-01268-y ER -
APA
Moghaddam, N. S., MohammadFakhim, B., Sharifi, M., Rajabian, A., Hariri, M., Khansari, M., Meigoli, M. S. S., Morovatshoar, R., Hosseini, S., Namini, N. J., Ghaedi, K., & Doaltabadi, N. F. (2024). hsa-miR-3529-5p through F2RL3 Regulation as an Enhancer of Sensitivity to Cisplatin. Indian Journal of Clinical Biochemistry. https://doi.org/10.1007/s12291-024-01268-y
Source records
- crossref · retrieved 2026-09-26T19:39:01.506Z